Neuregulin-ErbB and NMDA Receptor Signaling in Neuronal Development and Psychiatric Disorders

神经调节蛋白-ErbB 和 NMDA 受体信号在神经元发育和精神疾病中的作用

基本信息

项目摘要

1. Presynaptic accumulation of NRG3 in Central Neurons is Achieved by Trans-Synaptic Retention - a novel mechanism for polarized axonal expression of proteins: How stable axonal polarity is maintained remains a central question in neuroscience. We previously demonstrated that dual-TM proNRGs, comprised by CRD-NRG1 type III and NRG3, are targeted to axons and accumulate at glutamatergic presynaptic terminals where they signal in juxtacrine mode via postsynaptic ErbB4 receptors expressed at postsynaptic densities on GABAergic interneurons (Vullhorst, Ahmad et al., J Neurosci 2017). Our new study aimed to understand how and where proNRG3 is cleaved by BACE1, and how the resulting biologically active NRG3 peptide is sorted and selectively retained in axons. For this study an LOV-based optogenetic proNRG3 reporter (LA143-NRG3) was designed, which in response to blue light, it undergoes a conformational change that allows BACE1 to cleave proNRG3. Using LA143-NRG3, we found proNRG3 is retained in the TGN until cleaved by BACE1, then mature NRG3 emerges on the somatodendritic plasma membrane, and by transcytosis is re-endocytosed and anterogradely transported on Rab4+ vesicles into axons. Importantly, NRG3 accumulation at axonal presynaptic terminals is maintained by its continued trans-synaptic interaction with ErbB4 receptors expressed at postsynaptic glutamatergic synapses on GABAergic interneurons. We denote this novel mechanism "transsynaptic retention" and propose it can accounts for polarized axonal expression of other transmembrane ligands and receptors (Ref. 1). 2. Single-pass TM NRG2 in Central Neurons: Single-pass TM NRGs, such as NRG1 type II and NRG2, traffic as unprocessed pro-forms to the neuronal cell surface where they accumulate at ER-PM junctions on neuronal soma and proximal dendrites. Activation of excitatory glutamatergic NMDARs located on neuronal soma/dendrites promote calcium entry and activate phosphatases that dephosphorylate Ser/Thr residues in the proNRG2 intracellular region, resulting in the dissociation of proNRG2 from ER-PM junctions and ectodomain cleavage by the metalloproteinase ADAM10 (Vullhorst & Buonanno, Mol Neurobiol 2019). The released biologically active NRG2 binds and activates ErbB4 receptors expressed at postsynaptic excitatory glutamatergic synapses onto GABAergic interneurons, which in turn selectively downregulates NMDA excitatory currents (Vullhorst et al., Nat Comm 2015). We hypothesize that this bidirectional NMDAR-NRG2 (up)/ErbB4-NMDAR (down) signaling mode serves as a homeostatic mechanism that regulates the activity of GABAergic interneurons. A remaining challenge was to understand how proNRG2 clusters at ER-PM junctions, a site where Kv2.1 potassium channels also accumulate via their interaction with VAP, and how NMDAR activation causes their dissociation from the junction. Using a combination of cell biological and protein biochemical approaches, we identified two conserved protein sequences (denoted C- and D-boxes) in the cytoplasmic tails of proNRG1 and proNRG2 that interact with the ER-resident protein VAP to promote the formation of ER-PM contact sites on the proximal somatodendritic region of GABAergic interneurons. Although the sequences of C/D-boxes do not conform to canonical FFAT VAP-binding sites, the proNRG2 D-box contains acidic residues required for VAP binding and the C-box harbors a cryptic, phosphorylation-dependent VAP binding site. Importantly, NMDAR activation stimulates C-box Ser/Thr dephosphorylation, dissociation of proNRG2 from VAP and dispersion of NRG2 from ER-PM junctions. Based on these findings, we hypothesize that Kv2.1 channels and bidirectional NRG2/ErbB4 autocrine signaling function synergistically as a homeostatic mechanism both to protect fast-spiking parvalbumin-positive interneurons from excitotoxic damage and to regulate the activity of GABAergic interneurons, which affect E-I balance and neuronal network activity associated with psychiatric-relevant behaviors disrupted in NRG2 and ErbB4 knockout mice (Ref. 2). 3. Developmental, Neurochemical and Behavioral Analyses of ErbB4 Cyt-1 Knockout Mice: ErbB4 receptor transcripts are alternatively spliced to generate isoforms that either include (Cyt-1) or exclude (Cyt-2) exon 26; an exon that encodes a cytoplasmic domain that imparts on ErbB4 receptors the ability to signal via the PI3K/Akt pathway rather than the MAPK pathway. To investigate the effects of germline (constitutive) and conditional (acute) deletions of the Cyt-1 exon, we generated and studied ErbB4-floxed (ErbB4-Cyt1fl/fl ) mice because ErbB4 Cyt-1/2 isoforms had been only studied in cultured cells, and clinical studies implicated ErbB4 Cyt-1 variants as schizophrenia risk-factors. We found Cyt-1 knockouts only encode ErbB4 Cyt- 2 variants, but in contrast to ErbB4 null mice, GABAergic interneuron migration and number are unaltered in Cyt-1 KOs. Interestingly, basal extracellular dopamine (DA) levels are augmented in the medial prefrontal cortex of Cyt-1 mice but they don't manifest the behavioral abnormalities we observed in mice lacking ErbB4 in DA neurons. To address the possibility that Cyt-2 variants compensate for the lack of Cyt-1 during development, we microinjected AAV-Cre into the DA-rich VTA of adult ErbB4-Cyt1fl/fl mice to acutely target exon 26. These conditional Cyt-1 KOs were found to exhibit behavioral abnormalities in the elevated plus maze and startle response, consistent with the idea that late exon 26 ablations may circumvent compensation by Cyt-2 variants. Our findings suggest that ErbB4 Cyt-1 function in vivo is important for modulating DA levels and for regulating behaviors in adult mice (Refs. 3,4). 4. Pathway-specific contribution of parvalbumin interneuron NMDARs to synaptic currents and thalamocortical feedforward inhibition: The prefrontal cortex (PFC) is a site of convergence of long-range excitatory glutamatergic inputs that integrates multiple modalities of information to produce goal-directed behaviors, and drugs selectively targeting NMDA-type glutamate receptors alter PFC function and elicit numerous deficits associated with psychiatric disorders. Inhibitory GABAergic fast-spiking parvalbumin-expressing (PV+) interneurons are uniquely suited to coordinate the firing of pyramidal neurons in response to these converging excitatory inputs, and to induce gamma oscillations in cortical networks that modulate behaviors and that may be disrupted in several psychiatric disorders. Despite the importance of understanding how glutamatergic inputs onto PV+ interneurons affect network activity, behavior and disease, there continues to be controversy if both AMPA- and NMDA-type glutamate receptors or only AMPARs contribute to excitatory drive. We have used a combination of molecular, electrophysiological and optogenetic approaches, in combination with selective gene targeting techniques in PV+ interneurons, to resolve this long-standing controversy. We found that nearly 100% of PV+ interneurons in adult medial PFC express transcripts encoding GluN1 and GluN2B that assemble to form functional NMDARs. Importantly, by using selective optogenetic stimulation of corticocortical vs. thalamocortical inputs onto PV+ interneurons, we found that the relative synaptic NMDAR contribution to excitatory post-synaptic currents is pathway-specific. NMDARs contribute more at thalamocortical, rather than corticocortical, synapses. We then went on to demonstrate that PV+ interneuron NMDAR currents contribute to thalamus-mediated feedforward inhibition in PFC circuits. These findings demonstrating a molecular and circuit-based mechanisms for cognitive impairment under conditions of reduced NMDAR function, represent an important conceptual advance with implications for understanding the pathogenesis of psychiatric disorders (Re

项目成果

期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling.
  • DOI:
    10.1038/ncomms8222
  • 发表时间:
    2015-06-01
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Vullhorst, Detlef;Mitchell, Robert M.;Keating, Carolyn;Roychowdhury, Swagata;Karavanova, Irina;Tao-Cheng, Jung-Hwa;Buonanno, Andres
  • 通讯作者:
    Buonanno, Andres
The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.
  • DOI:
    10.1016/j.brainresbull.2010.07.012
  • 发表时间:
    2010-09-30
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Buonanno A
  • 通讯作者:
    Buonanno A
Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity.
神经调节蛋白连接多巴胺能和谷氨酸能神经传递以控制海马突触可塑性。
  • DOI:
    10.4161/cib.2.3.7825
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Neddens,Jorg;Vullhorst,Detlef;Paredes,Daniel;Buonanno,Andres
  • 通讯作者:
    Buonanno,Andres
Detection and Quantification of Multiple RNA Sequences Using Emerging Ultrasensitive Fluorescent In Situ Hybridization Techniques.
  • DOI:
    10.1002/cpns.63
  • 发表时间:
    2019-04-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Erben, Larissa;Buonanno, Andres
  • 通讯作者:
    Buonanno, Andres
Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3.
  • DOI:
    10.1083/jcb.202110167
  • 发表时间:
    2022-07-04
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    Ahmad, Tanveer;Vullhorst, Detlef;Chaudhuri, Rituparna;Guardia, Carlos M.;Chaudhary, Nisha;Karavanova, Irina;Bonifacino, Juan S.;Buonanno, Andres
  • 通讯作者:
    Buonanno, Andres
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDRES BUONANNO其他文献

ANDRES BUONANNO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDRES BUONANNO', 18)}}的其他基金

TRANSCRIPTIONAL MECHANISMS REGULATING ACTIVITY DEPENDENT GENE EXPRESSION
调节活性依赖性基因表达的转录机制
  • 批准号:
    6290193
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Neuregulin-ErbB Signaling in Neuronal Development and Psychiatric Disorders
神经元发育和精神疾病中的神经调节蛋白-ErbB 信号转导
  • 批准号:
    8553854
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Mechanisms Regulating Activity Dependent Synaptic Plasticity and Gene Expression
调节活动依赖性突触可塑性和基因表达的机制
  • 批准号:
    8351117
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Neuregulin-ErbB Signaling in Neuronal Development and Psychiatric Disorders
神经元发育和精神疾病中的神经调节蛋白-ErbB 信号转导
  • 批准号:
    10004466
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Mechanisms Regulating Activity Dependent Synaptic Plasti
调节活动依赖性突触塑性的机制
  • 批准号:
    7208203
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Transcriptional Mechanisms Regulating Gene Expression
调节基因表达的转录机制
  • 批准号:
    6813772
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Mechanisms Regulating Activity Dependent Synaptic Plasticity and Gene Expression
调节活动依赖性突触可塑性和基因表达的机制
  • 批准号:
    7968532
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Neuregulin-ErbB and NMDA Receptor Signaling in Neuronal Development and Psychiatric Disorders
神经调节蛋白-ErbB 和 NMDA 受体信号在神经元发育和精神疾病中的作用
  • 批准号:
    10672079
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Neuregulin-ErbB Signaling in Neuronal Development and Psychiatric Disorders
神经元发育和精神疾病中的神经调节蛋白-ErbB 信号转导
  • 批准号:
    10266463
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:
Mechanisms Regulating Activity Dependent Synaptic Plasticity and Gene Expression
调节活动依赖性突触可塑性和基因表达的机制
  • 批准号:
    8149251
  • 财政年份:
  • 资助金额:
    $ 144.55万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 144.55万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了